Controversies in the Management of Central Nervous System Coccidioidomycosis.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
10 09 2022
Historique:
received: 11 04 2022
pubmed: 20 6 2022
medline: 14 9 2022
entrez: 19 6 2022
Statut: ppublish

Résumé

Central nervous system infection with Coccidioides spp. is fatal if untreated and complications occur even when therapy is directed by experienced clinicians. We convened a panel of clinicians experienced in the management of coccidioidal meningitis to summarize current controversies and provide consensus for the management of this difficult infection.

Identifiants

pubmed: 35717645
pii: 6611484
doi: 10.1093/cid/ciac478
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-559

Informations de copyright

The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. G. R. T.: Grants and consulting: Astellas, Cidara, Mayne, F2G, Scynexis; Grants: Merck; DSMB: Pfizer. D. A. S.: Grants: Valley Fever Solutions (support studies on nikkomycin). Research contracts for animal model and in vitro studies (no clinical studies). All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

George R Thompson (GR)

Department of Internal Medicine, Division of Infectious Diseases and the Department of Medical Microbiology and Immunology, University of California-Davis Medical Center, Sacramento, California, USA.
University of California-Davis Center for Valley Fever, Sacramento, California, USA.

Neil M Ampel (NM)

Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, Arizona, USA.

Janis E Blair (JE)

Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.

Fariba Donovan (F)

Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, Arizona, USA.
Valley Fever Center for Excellence, University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.

Joshua Fierer (J)

Division of Infectious Disease, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California, USA.
Infectious Diseases Section, VA Healthcare San Diego, San Diego, California, USA.

John N Galgiani (JN)

Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, Arizona, USA.
Valley Fever Center for Excellence, University of Arizona College of Medicine-Tucson, Tucson, Arizona, USA.

Arash Heidari (A)

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Kern Medical, Bakersfield, California, USA.
Valley Fever Institute, Kern Medical Center, Bakersfield, California, USA.

Royce Johnson (R)

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Kern Medical, Bakersfield, California, USA.
Valley Fever Institute, Kern Medical Center, Bakersfield, California, USA.

Stanley A Shatsky (SA)

Department of Neurosurgery, Good Samaritan Hospital, San Jose, California, USA.

Christopher M Uchiyama (CM)

Department of Neurosurgery, Scripps Clinic and Scripps Green Hospital, La Jolla, California, USA.

David A Stevens (DA)

California Institute for Medical Research, San Jose, California, USA.
Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH